Adamas Pharmaceuticals Inc
|
Q1 2020
Filed on May 12, 2020
|
46,000
|
N/A
|
|
|
Q1 2020
Filed on May 12, 2020
|
13,800
|
$32.84 - $56.63
$453K - $781K
|
|
Beasley Broadcast Group Inc
|
Q1 2020
Filed on May 12, 2020
|
55,167
|
N/A
|
|
|
Q1 2020
Filed on May 12, 2020
|
500,000
|
N/A
|
|
|
Q1 2020
Filed on May 12, 2020
|
38,967
|
N/A
|
|
|
Q1 2020
Filed on May 12, 2020
|
9,602
|
$20.24 - $29.59
$194K - $284K
|
|
|
Q1 2020
Filed on May 12, 2020
|
50,000
|
$3.86 - $8.32
$193K - $416K
|
|
|
Q1 2020
Filed on May 12, 2020
|
300,000
|
N/A
|
|
|
Q1 2020
Filed on May 12, 2020
|
348,263
|
$2.03 - $4.35
$707K - $1.51M
|
|
|
Q1 2020
Filed on May 12, 2020
|
14,000
|
$23.99 - $59.09
$336K - $827K
|
|
|
Q1 2020
Filed on May 12, 2020
|
160,099
|
$1.54 - $6.75
$247K - $1.08M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
400,000
|
$61.37 - $64.82
$24.5M - $25.9M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
32,740
|
$4.2 - $6.54
$138K - $214K
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
30,000
|
$34.1 - $41.36
$1.02M - $1.24M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
8,339
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
1,500,000
|
$0.63 - $2.27
$945K - $3.41M
|
|
Power Shares Qqq Trust, Series 1 (Etf)
|
Q4 2019
Filed on Feb 10, 2020
|
800,000
|
N/A
|
|
Crescent Acquisition Corp
|
Q4 2019
Filed on Feb 10, 2020
|
100,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
377,194
|
N/A
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
50,000
|
$10.74 - $20.0
$537K - $1M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
30,000
|
$17.72 - $25.1
$532K - $753K
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
100,000
|
$14.69 - $18.44
$1.47M - $1.84M
|
|
|
Q4 2019
Filed on Feb 10, 2020
|
4,000
|
$102.4 - $164.28
$410K - $657K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
30,000
|
$26.17 - $35.07
$785K - $1.05M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
2,000
|
$266.44 - $303.77
$533K - $608K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
900,000
|
$1.12 - $5.12
$1.01M - $4.61M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
32,316
|
$13.86 - $20.67
$448K - $668K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
5,000
|
$60.08 - $88.17
$300K - $441K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
50,000
|
$11.88 - $16.72
$594K - $836K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
58,647
|
$2.72 - $4.48
$160K - $263K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
60,000
|
$14.12 - $23.44
$847K - $1.41M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
250,000
|
N/A
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
121,351
|
$5.29 - $8.52
$642K - $1.03M
|
|
Adamas Pharmaceuticals Inc
|
Q3 2019
Filed on Oct 30, 2019
|
54,822
|
N/A
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
8,000
|
$72.81 - $156.91
$582K - $1.26M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
178,571
|
$1.25 - $5.0
$223K - $893K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
149,441
|
N/A
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
123,000
|
N/A
|
|
Eyepoint Pharmaceuticals Inc
|
Q2 2019
Filed on Jul 29, 2019
|
329,000
|
N/A
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
900,000
|
$7.32 - $11.24
$6.59M - $10.1M
|
|
Innovate Biopharmaceuticls I
|
Q2 2019
Filed on Jul 29, 2019
|
429,184
|
N/A
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
123,176
|
$3.56 - $6.9
$439K - $850K
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
60,000
|
$10.85 - $15.97
$651K - $958K
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
2,000
|
$206.87 - $231.91
$414K - $464K
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
20,000
|
$15.04 - $18.64
$301K - $373K
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
10,100
|
N/A
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
20,000
|
$44.62 - $49.34
$892K - $987K
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
1,000,000
|
N/A
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
650,000
|
$30.12 - $36.63
$19.6M - $23.8M
|
|
|
Q2 2019
Filed on Jul 29, 2019
|
1,033,333
|
N/A
|
|